Navigation Links
Regulatory Affairs: The Key to Russia, New Life Science Webinar Hosted by Xtalks
Date:3/20/2013

Toronto, Canada (PRWEB) March 20, 2013

The regulatory environment in Russia changes rapidly – new clinical trial regulations and restrictions are introduced almost every quarter.

Our panel of leading Russian industry and government experts will help you navigate successfully through the sea of changes. Don’t miss this unique opportunity to interact with one of the co-authors of new amendments to the Russian Federal Law on Circulation of Drugs.

This webinar will include three insightful presentations:

  •     Dr. Yuri Afonchikov, Synergy’s VP for Regulatory Affairs, will discuss the Russian regulatory system through the eyes of a European expert
  •     Dr. Sergei Glagolev, one of the leading experts of the Federal Service on Surveillance in Healthcare (Roszdravnadzor) will discuss biosimiliars, pharmacovigilance and legal amendments in Russia
  •     Mr. Igor Stefanov, Synergy’s General Manager and a proponent of openness and transparency in the Russian CRO business, will analyze the current state of the clinical trial market in Russia and review the upcoming 2013 trends as well as historical data

For more information about this event or to register, visit: http://xtks.in/xto579-event.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year, thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/3/prweb10548873.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
2. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
3. ADVENTRX Announces Establishment of Regulatory Advisory Board
4. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
5. Healthcare, Regulatory and Reimbursement Landscape - Australia
6. Northwest Bio Receives Regulatory Approval To Proceed With Its Phase III Trial In The UK
7. Sanguine Appoints Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to Clinical Advisory Board and Ethics Committee
8. RAPS, Eucomed Partner to Provide Online Training to Regulatory Professionals Throughout Europe
9. Webinar on Clinical, Regulatory and Commercialization Strategies for Rare Diseases
10. Webinar to Discuss Biosimilar Regulatory Guidelines in India and Emerging Markets
11. Global Regulatory Milestones for Invibio Biomaterial Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 23, 2017 , ... Calvert Labs, Inc. announced today that ... Director, Safety Pharmacology. Dr. Thomas earned his M.Sc. and Ph.D. in Pharmacology ... an academic and industry preclinical drug developer spans more than three decades. ...
(Date:1/21/2017)... ... 20, 2017 , ... G&L Scientific Inc, a leading provider ... ), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and ... This is the latest step in G&L’s expansion of its global clinical consulting ...
(Date:1/21/2017)... 20, 2017 Bioptix, Inc. (Nasdaq: ... that on January 14, 2017 the Board of Directors ... Company will terminate certain employees associated with the September ... Company commenced terminations on January 16, 2017 and terminations ... Company may pay severance benefits in certain circumstances of ...
(Date:1/20/2017)... -- Stock-Callers.com explores the Biotech industry to ... recent performances of select equities. In this morning,s lineup ... Abeona Therapeutics Inc. (NASDAQ: ABEO ), Theravance ... Therapeutics Inc. (NASDAQ: SAGE ). According to ... market size is expected to reach $604.40 billion by 2020 due to ...
Breaking Biology Technology:
(Date:1/18/2017)... MedNet Solutions , an innovative ... spectrum of clinical research, is proud to announce ... the organization in terms of corporate growth, outside ... and services. The company,s exceptional achievements can be ... iMedNet ™ – MedNet,s ...
(Date:1/12/2017)... PUNE, India , January 12, 2017 A new report ... 2022," projects that the global biometric technology market is expected to generate revenue of ... Continue Reading ... Allied ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/6/2017)... 5, 2017  SomaLogic announced today that it ... established by iCarbonX, the China ... "Global Digital Health Ecosystem that can define each ... individual,s biological, behavioral and psychological data, the Internet ... companies, SomaLogic will provide proteomics data and applications ...
Breaking Biology News(10 mins):